Skip to main content
. 2018 Jun 1;10:164. doi: 10.3389/fnagi.2018.00164

FIGURE 3.

FIGURE 3

Fluoxetine enhances the non-amyloidogenic pathway in 3×Tg-AD mice brain. (A) The western blot analysis was used to examine the expression levels of APP and APP cleavage enzymes, including APP, CTFβ, CTFα, ADAM10, BACE1, and PS1. (B) Levels of APP cleavage fragments, including sAPPα, sAPPβ, C83, and C99 generation, in the brain of three groups were assessed and quantified by immunoblotting. WT, wild-type mice; Tg: 3×Tg-AD mice; Tg + FLX: fluoxetine treated 3×Tg-AD mice. All data were shown as mean ± SD, n = 12 animals/group. p < 0.05, ∗∗p < 0.01.